WTX-330

· Werewolf Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for WTX-330, covering 2026-01-06 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma [Phase 1, Phase 2]

See pricing